Economic evaluation of home medication review by community pharmacists (HMR-CP) for patients with type 2 diabetes mellitus (T2DM)

Rosli, M. Rozaini; Wu, David Bin-Chia; Neoh, Chin Fen; Karuppannan, Mahmathi

doi:10.1080/13696998.2021.1889573

Cited by 8 publications

(21 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, no studies were identified through forward and backward searches. Finally, 11 articles met the selection criteria and were included in the review (see Figure 1 for the PRISMA flow diagram) [ 41 , 42 , 43 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 ].…”

Section: Resultsmentioning

confidence: 99%

“…The included studies were conducted in Bangladesh [ 48 ], China [ 47 , 52 ] including Hong Kong [ 51 ], India [ 41 , 43 , 49 ], Malaysia [ 54 ], Singapore [ 42 , 50 ], and Sri Lanka [ 53 ] with T2DM patients and participants who were at high risk of developing T2DM. Participants included in the studies were aged 5 years and above, and the average sample size of the studies was 920 participants (study samples ranged between 166 and 3539 participants).…”

Section: Resultsmentioning

confidence: 99%

“…Participants included in the studies were aged 5 years and above, and the average sample size of the studies was 920 participants (study samples ranged between 166 and 3539 participants). The studies used a Markov model [ 47 , 51 , 53 , 54 ], decision tree [ 42 ], or randomized controlled trial [ 41 , 43 , 48 , 49 , 50 , 51 , 52 , 53 ] to make a cost-effectiveness projection. The period for the potential effectiveness of the interventions was simulated from six months to a lifetime, and all studies performed a cost-effectiveness analysis of the health behavior interventions.…”

Section: Resultsmentioning

confidence: 99%

“…One study used six years of regular health screening (i.e., initial 2 h post-glucose test for 3 months, confirmatory diagnosis test, and annual physical examination) implemented by a health worker in a health center, and counseling on health behavior change at the 3-month follow-up with a physical examination up to one year later [ 47 ]. Finally, one study provided counseling on medication adherence, lifestyle modification, and self-glucose monitoring by a community pharmacist and family medicine physician every 3 months [ 54 ].…”

Section: Resultsmentioning

confidence: 99%

“…Nine studies used a cost-effectiveness threshold for decision making (i.e., deciding to promoting a health behavior over an alternative intervention) that reflected the maximum willingness to pay per unit of the health outcome [ 41 , 42 , 43 , 47 , 48 , 50 , 51 , 53 , 54 ]. Five of nine studies used a cost-effectiveness threshold decision rule proposed by WHO [ 41 , 42 , 43 , 48 , 53 ].…”

Section: Resultsmentioning

confidence: 99%

See 4 more Smart Citations

Economic Evaluation of Health Behavior Interventions to Prevent and Manage Type 2 Diabetes Mellitus in Asia: A Systematic Review of Randomized Controlled Trials

Dahal

Rawal

Mahumud

et al. 2022

IJERPH

View full text Add to dashboard Cite

Health behavior interventions implemented in Asian countries often lack economic evaluations that effectively address the problems of type 2 diabetes mellitus. This review systematically assessed the existing literature on economic evaluation of health behavior interventions to prevent and manage type 2 diabetes mellitus for people living in Asian countries. Eligible studies were identified through a search of six bibliographic databases, namely, PubMed, Scopus, Public Health Database by ProQuest, Cumulative Index to Nursing and Allied Health Literature Complete, Web of Science, and Google Scholar. Randomized controlled trials of health behavior interventions and studies published in the English language from January 2000 to May 2022 were included in the review. The search yielded 3867 records, of which 11 studies were included in the review. All included studies concluded that health behavior interventions were cost-effective. Eight of these studies undertook an evaluation from a health system perspective, two studies used both societal and health system perspectives, and one study utilized a societal and multi-payer perspective. This review identified the time horizon, direct and indirect medical costs, and discount rates as the most important considerations in determining cost effectiveness. These findings have implications in extending health behavior interventions to prevent and manage type 2 diabetes mellitus in low-resource settings, and are likely to yield the most promising outcomes for people with type 2 diabetes mellitus.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 3 more Smart Citations

Economic Evaluation of Health Behavior Interventions to Prevent and Manage Type 2 Diabetes Mellitus in Asia: A Systematic Review of Randomized Controlled Trials

Dahal

Rawal

Mahumud

et al. 2022

IJERPH

View full text Add to dashboard Cite

show abstract

Cost-Effectiveness of Pharmacist Care in Diabetes Management: A Systematic Review

Zhu,

Zhou,

Wang

2023

Diabetes Ther

View full text Add to dashboard Cite

Introduction In recent years, the role of pharmacists has undergone significant transformation to become more patient-centered and involved in managing chronic diseases. Nonetheless, it remains unclear whether pharmacist involvement in diabetes management is cost-effective. This study aimed to systematically review the cost-effectiveness and reporting quality in comprehensive economic evaluations of pharmacist management compared to standard care in diabetes. Methods Eligible studies included cost-effectiveness analyses employing pharmacist professional services as the intervention for diabetes. A literature search was conducted in the bibliographic databases Pubmed, Scopus, China National Knowledge Infrastructure (CNKI), and the International Health Technology Assessment (HTA) database from their inception until July 2023. Two independent reviewers performed title, abstract, full-text screening, and data abstraction and assessed the quality of reporting and methodological approaches using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS 2022) checklists. Results Twelve studies were identified with an average research quality score of 19.8, including cost-utility ( n = 5) and cost-effectiveness ( n = 7) analyses, with only four studies rated as high quality. The efficacy data were derived from randomized controlled trials ( n = 7), retrospective studies ( n = 2), and published literature sources ( n = 2). Half of the included studies were conducted in high-income countries, while the other half was in upper-middle and lower-middle-income countries, respectively. Despite significant variations in the cost of pharmacist intervention, consistent findings demonstrate that pharmacist involvement in diabetes management is more cost-effective or even cost-saving than standard care, primarily attributed to better glycemic control, enhanced patient compliance, and reduced risks of medication-related problems. Conclusion This systematic review substantiates that pharmacist involvement in diabetes management is cost-effective compared with standard care. However, the overall quality of reporting needs to be improved, and high-quality evidence is urgently needed to support healthcare decision-making in pharmacy practice. Supplementary Information The online version contains supplementary material available at 10.1007/s13300-023-01505-2.

show abstract

A systematic review of economic evaluations of pharmacist services

Price,

Shirtcliffe,

Fisher

et al. 2023

International Journal of Pharmacy Practice

View full text Add to dashboard Cite

Background Challenges to the provision of health care are occurring internationally and are expected to increase in the future, further increasing health spending. As pharmacist roles are evolving and expanding internationally to provide individualised pharmaceutical care it is important to assess the cost-effectiveness of these services. Objectives To systematically synthesise the international literature regarding published economic evaluations of pharmacy services to assess their cost-effectiveness and clinical outcomes. Methods A systematic review of economic evaluations of pharmacy services was conducted in MEDLINE, EMBASE, PubMed, Scopus, Web of Science, CINAHL, IPA and online journals with search functions likely to publish economic evaluations of pharmacy services. Data were extracted regarding the interventions, the time horizon, the outcomes and the incremental cost-effectiveness ratio. Studies’ quality of reporting was assessed using the Consolidated Health Economic Evaluation Reporting Standard (CHEERS) statement. Results Seventy-five studies were included in the systematic review, including 67 cost-effectiveness analyses, 6 cost-benefit analyses and 2 cost-consequence analyses. Of these, 57 were either dominant or cost-effective using a willingness-to-pay threshold of NZ$46 645 per QALY. A further 11 studies’ cost-effectiveness were unable to be evaluated. Interventions considered to be most cost-effective included pharmacist medication reviews, pharmacist adherence strategies and pharmacist management of type 2 diabetes mellitus, hypertension and warfarin/INR monitoring. The quality of reporting of studies differed with no studies reporting all 28 items of the CHEERS statement. Conclusions There is strong economic evidence to support investment in extended pharmacist services, particularly those focussed on long-term chronic health conditions.

show abstract

Economic evaluation of home medication review by community pharmacists (HMR-CP) for patients with type 2 diabetes mellitus (T2DM)

Abstract: View related articles View Crossmark data Economic evaluation of home medication review by community pharmacists (HMR-CP) for patients with type 2 diabetes mellitus (T2DM)

Cited by 8 publications

References 40 publications

Economic Evaluation of Health Behavior Interventions to Prevent and Manage Type 2 Diabetes Mellitus in Asia: A Systematic Review of Randomized Controlled Trials

Economic Evaluation of Health Behavior Interventions to Prevent and Manage Type 2 Diabetes Mellitus in Asia: A Systematic Review of Randomized Controlled Trials

Cost-Effectiveness of Pharmacist Care in Diabetes Management: A Systematic Review

A systematic review of economic evaluations of pharmacist services

Contact Info

Product

Resources

About